4//SEC Filing
BLONDER TONGUE LABORATORIES INC 4
Accession 0001140361-17-014940
$BDRLCIK 0001000683operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:37 PM ET
Size
16.3 KB
Accession
0001140361-17-014940
Insider Transaction Report
Form 4
Dietz Charles E
Director
Transactions
- Award
Common Stock, par value $0.001
2017-04-04+10,000→ 191,086 total - Award
Common Stock, par value $0.001
2017-04-04$0.55/sh+19,182$10,550→ 210,268 total - Award
Stock Option (right to buy)
2017-04-04+10,000→ 10,000 totalExercise: $0.55Exp: 2027-04-04→ Common Stock par value $0.001 (10,000 underlying)
Footnotes (5)
- [F1]Grant of stock award under 2016 Director Equity Incentive Plan.
- [F2]Pursuant to the company's Amended and Restated Director Stock Purchase Plan, the reporting person has elected to receive a fully vested stock award for shares of the company's common stock in lieu of cash payment of director fees otherwise payable to the reporting person. The number of shares of common stock awarded represents the quotient of (i) the director fees payable to the reporting person divided by (ii) $0.55, representing the average of the high and low trading prices reported on the NYSE MKT on April 4, 2017.
- [F3]The stock option was granted under the 2016 Director Equity Incentive Plan.
- [F4]The exercise price equals the fair market value (equal to the average of the high and low selling prices as reported on the NYSE MKT) of the common stock on the grant date.
- [F5]The stock option vests on the first anniversary of the grant date.
Issuer
BLONDER TONGUE LABORATORIES INC
CIK 0001000683
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001000683
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:37 PM ET
- Size
- 16.3 KB